At #AACR26, Ece Koçak and Dr. Megan King share how PARP inhibitors increase DNA “bridges” in BRCA-deficient cancer cells that can rupture the nucleus, exposing DNA and triggering immune signaling. Linking DNA damage to immune activation. @MCDB_Yale @AACR @OncoAlert https://t.co/RbdGHUtj1r